Afuco™ Anti-Human TAG-72 ADCC Therapeutic Antibody (CC49), ADCC Enhanced

Anti-TAG-72 ADCC Enhanced Antibody (CC49) is an ADCC enhanced antibody produced by our Afuco™ platform. CC49 is an antibody reactive to tumor-associated glycoprotein (TAG-72), has been extensively studied in targeted radionuclide therapy trials for colon cancers.
Supplier Creative Biolabs
Product # AFC-569CL
Pricing Inquiry
Host Humanized
Target TAG-72
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at –20 or -70°C upon receipt. Divide antibody into aliquots prior usage and avoid multiple freeze-thaw cycles.
Feedback